Skip to main content
Top
Published in: Clinical Rheumatology 3/2017

01-03-2017 | Brief Report

Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report

Authors: J. Sepúlveda-Delgado, O. L. Vera-Lastra, K. Trujillo-Murillo, L.M. Canseco-Ávila, R.A. Sánchez-González, O. Gómez-Cruz, A. Lugo-Trampe, I. Fernández-Salas, R. Danis-Lozano, A. Contreras-Contreras, A. Mendoza-Torres, S. Domínguez-Arrevillaga, B.A. Mena-Vela, M. Ocaña-Sibilla, J.C. Ramirez-Valdespino, L.J. Jara

Published in: Clinical Rheumatology | Issue 3/2017

Login to get access

Abstract

The chikungunya virus (ChikV) is a reemerging mosquito-borne pathogen that causes disabling chronic arthritis. The relationship between clinical evolution and inflammatory biomarkers in patients with ChikV-induced arthritis has not been fully described. We performed a prospective case series to evaluate the association among joint involvement, self-reported disability, and inflammatory biomarkers. Patients with ChikV infection were followed for 1 year. Joint involvement and self-reported disability were evaluated with disease activity index 28 (DAS-28) and World Health Organization Disablement Assessment Schedule II (WHODAS-II). Interleukin-6 (IL-6), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF) were used as biomarkers. Ten patients with mean age 48 ±15.04 years were included. Symptoms at diagnosis were fever, arthralgias, myalgias, rash, arthritis, nausea, vomiting, and back pain. Polyarticular involvement was present in seven cases. At diagnosis, measures were as follows: DAS-28, 5.08±1.11; WHODAS-II score, 72.3±10.3 %; CRP, 5.09±7.23 mg/dL; ESR, 33.5±17.5 mm/h; RF, 64±21.7 IU/mL; and IL-6, 17.6±10.3 pg/mL. Six patients developed subacute and chronic symptoms. During follow-up, DAS-28 index, WHODAS-II score, ESR, and IL-6 were statistically different in patients with subacute and chronic symptoms compared to those who resolved in the acute phase (p < 0.05). DAS-28 index, WHODAS-II score, and IL-6 were related to chronicity of articular symptoms and could be used as predictors of ChikV-induced arthritis.
Literature
1.
go back to reference Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nature. Rev Microbiol 8:491–500 Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nature. Rev Microbiol 8:491–500
2.
go back to reference Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 37:1231–1239 Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 37:1231–1239
5.
go back to reference Manimunda SP, Vijayachari P, Uppoor R et al (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399CrossRefPubMed Manimunda SP, Vijayachari P, Uppoor R et al (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399CrossRefPubMed
6.
go back to reference Chen W, Foo SS, Sims NA et al (2015) Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol 23:35–43CrossRefPubMed Chen W, Foo SS, Sims NA et al (2015) Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol 23:35–43CrossRefPubMed
7.
go back to reference Chow A, Zhisheng H, Ong E et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral Chow A, Zhisheng H, Ong E et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral
8.
go back to reference Lohachanakul J, Weerawat P, Thannagith M et al (2012) High concentrations of circulating interleukin 6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56:134–138CrossRefPubMed Lohachanakul J, Weerawat P, Thannagith M et al (2012) High concentrations of circulating interleukin 6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56:134–138CrossRefPubMed
10.
go back to reference Singh JA, Saag KG, Jr SLB et al (2015) American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care& Research. doi:10.1002/acr.22783 Singh JA, Saag KG, Jr SLB et al (2015) American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care& Research. doi:10.​1002/​acr.​22783
11.
go back to reference Chopra A, Anuradha V, Ghorpade R et al (2012) Acute chikungunya (CHIKV) and persistent musculoskeletal pain following the 2006 Indian epidemic: a two year prospective rural community study. Epidemiol Infect 140:842–850CrossRefPubMed Chopra A, Anuradha V, Ghorpade R et al (2012) Acute chikungunya (CHIKV) and persistent musculoskeletal pain following the 2006 Indian epidemic: a two year prospective rural community study. Epidemiol Infect 140:842–850CrossRefPubMed
12.
go back to reference Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444CrossRefPubMed Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444CrossRefPubMed
13.
go back to reference Arroyo-Ávila M, Vilá LM (2015) Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J 34:71–77PubMed Arroyo-Ávila M, Vilá LM (2015) Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J 34:71–77PubMed
14.
go back to reference Rodríguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzón SF, Hurtado-Zapata JS (2016) Prevalence of post-chikungunya chronic inflammatory rheumatism: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). doi:10.1002/acr.22900 Mar 25, [Epub ahead of print] Rodríguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzón SF, Hurtado-Zapata JS (2016) Prevalence of post-chikungunya chronic inflammatory rheumatism: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). doi:10.​1002/​acr.​22900 Mar 25, [Epub ahead of print]
15.
go back to reference Hawman DW, Stoermer KA, Montgomery SA et al (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888CrossRefPubMedPubMedCentral Hawman DW, Stoermer KA, Montgomery SA et al (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888CrossRefPubMedPubMedCentral
17.
go back to reference Chow A, Her Z, Ong EK et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral Chow A, Her Z, Ong EK et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral
Metadata
Title
Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report
Authors
J. Sepúlveda-Delgado
O. L. Vera-Lastra
K. Trujillo-Murillo
L.M. Canseco-Ávila
R.A. Sánchez-González
O. Gómez-Cruz
A. Lugo-Trampe
I. Fernández-Salas
R. Danis-Lozano
A. Contreras-Contreras
A. Mendoza-Torres
S. Domínguez-Arrevillaga
B.A. Mena-Vela
M. Ocaña-Sibilla
J.C. Ramirez-Valdespino
L.J. Jara
Publication date
01-03-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3419-2

Other articles of this Issue 3/2017

Clinical Rheumatology 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.